Candel Therapeutics, Inc. Common Stock
Symbol: CADL (NASDAQ)
4.93
▲ (1.55%) 0.075
Company Description:
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Key Stats
- Today's Open: $4.85
- Today's High: $5.005
- Today's Low: $4.85
- Today's Volume: 151.89K
- Yesterday Close: $4.85
- Yesterday High: $4.98
- Yesterday Low: $4.81
- Yesterday Volume: 739.63K
- Last Min Volume: 1.82K
- Last Min High: $4.935
- Last Min Low: $4.925
- Last Min VWAP: $4.93352
Company Profile
- Name: Candel Therapeutics, Inc. Common Stock
- Website: https://www.candeltx.com
- Listed Date: 2021-07-27
- Location: NEEDHAM, MA
- Market Status: Active
- CIK Number: 0001841387
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $266.24M
- Round Lot: 100
- Outstanding Shares: 54.90M
- Asset Type: CS
RECENT FILINGS FOR CADL
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-22 | EFFECT | View |
| 2025-08-21 | 8-K | View |
| 2025-08-14 | S-3 | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-07-30 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-06-30 | 144 | View |
| 2025-06-30 | SCHEDULE 13G | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-26 | 4 | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 8-K | View |
Latest News on CADL